DANZITEN vs OFEV

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 13, 2026·How we rate

Possible drug interaction. DANZITEN and OFEV are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	OFEV
Rating	70/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	NINTEDANIB ESYLATE
Manufacturer	Azurity	Boehringer Ingelheim
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Idiopathic Pulmonary Fibrosis

danziten ofev

Rating

70/100

72/100

Pharmacy pays

—

Type

Active ingredient

NILOTINIB TARTRATE

NINTEDANIB ESYLATE

Manufacturer

Azurity

Boehringer Ingelheim

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Idiopathic Pulmonary Fibrosis

Frequently asked questions

Which is better-rated, Danziten or Ofev?

By our independent rating, Ofev scores higher — 3.6 vs 3.5 out of 5 for Danziten. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Danziten and Ofev?

Danziten contains Nilotinib Tartrate, while Ofev contains Nintedanib Esylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.